The global eClinical solutions market is estimated to reach 7.61 Billion by 2022, at a CAGR of 12.4% during the forecast period (2017-2022). Adoption of novel software solutions during clinical research and rising government funding to support clinical trials are key factors fueling the growth of the market. —
Download Brochure of eClinical Solutions Market spread across 163 Pages, Profiling 13 Companies and Supported with 72 Tables and 40 Figures is now available at http://www.rnrmarketresearch.com/contacts/request-sample?rname=57734 .
Geographically, North America commanded largest share of eClinical solutions market in 2016, followed by Europe. A number of factors like increasing government grants to support clinical trials, continuous product development and launch by eClinical solution vendors, growth in number of partnerships for new drug development, high prevalence of lifestyle diseases, & an increasing aging population are further stimulating demand for eClinical solutions in North America.
Key Target Audience
• Healthcare IT Service Providers
• eClinical Solution Vendors
• Clinical Research Organizations
• Pharmaceutical/Biopharmaceutical Companies
• Research and Development (R&D) Companies
• Business Research and Consulting Service Providers
• Medical Research Laboratories
• Academic Medical Centers/Universities/Hospitals
The eClinical solutions market is estimated to witness phenomenal growth over the forecast period. Technological advancements in the field of clinical trials such as electronic data capture and prevalence of Wi-Fi connectivity are projected to drive the market in coming years.
Get 25% Discount on eClinical Solutions Market with Top Trends, Company Profiles, Forecast and Analysis at http://www.rnrmarketresearch.com/contacts/discount?rname=57734 .
Global eClinical solutions market is divided into phase I, phase II, phase III, and phase IV. The phase III clinical trials segment accounted for the largest share of the global eClinical solutions market in 2016. In addition, the phase III clinical trials segment is expected to grow at the highest CAGR during the forecast period.
Key business strategies in eClinical Solutions Market are Medidata Solutions, Inc. (U.S.) PAREXEL International Corporation (U.S.), BioClinica, Inc. (U.S.), CRF Health (U.S.), DATATRAK International, Inc. (U.S.), ERT (U.S.), MaxisIT Inc. (U.S.), Bio-Optronics, Inc. (U.S.), eClinical Solutions, Inc. (U.S.), Merge Healthcare Incorporated (U.S.), and OmniComm Systems, Inc. (U.S.).
More Information on “eClinical Solutions Market by Product (CDMS, EDC, CTMS, eCOA, Analytics, RTMS, eTMF, Safety), Delivery Mode (On-Demand, On-premise, Cloud-based), Clinical Trial Phases, End User (Pharma/Biopharma Companies, CROs, Hospitals) - Global Forecast to 2022” report at http://www.rnrmarketresearch.com/contacts/inquire-before-buying?rname=57734 .
Emerging markets including China, South Korea, Taiwan, and India are attractive destinations for outsourcing clinical trials due to the presence of a large patient population and the low operating cost of conducting clinical trials in these countries.
Global eClinical Solutions Market, by End User
• Pharmaceutical and Biopharmaceutical Companies
• Contract Research Organizations
• Consulting Service Companies
• Medical Device Manufacturers
• Academic Research Institutions
Less stringent regulatory guidelines compared to developed nations, shortage of trial volunteers in Europe and North America, and the growing number of life science research companies and CROs are key factors propelling the demand for eClinical solutions in these emerging markets. In order to leverage the high growth opportunities, leading market players are expanding their presence in these nations.
Name: Mr. Vishal
Email: Send Email
Address: Tower B5, Office 101, Magarpatta City SEZ, Pune-411013, India
Phone: +1 888 391 5441
Release ID: 462208